| Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users TR Spindle, EJ Cone, E Goffi, EM Weerts, JM Mitchell, RE Winecker, ... Drug and alcohol dependence 211, 107937, 2020 | 112 | 2020 |
| Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized … DJ Sholler, TR Spindle, EJ Cone, E Goffi, D Kuntz, JM Mitchell, ... Journal of Analytical Toxicology 46 (5), 494-503, 2022 | 28 | 2022 |
| Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products CL Bergeria, TR Spindle, EJ Cone, D Sholler, E Goffi, JM Mitchell, ... Journal of analytical toxicology 46 (6), 583-591, 2022 | 18 | 2022 |
| A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products AN Dowd, CA Zamarripa, DJ Sholler, JC Strickland, E Goffi, ... Drug and alcohol dependence 245, 109826, 2023 | 1 | 2023 |
